Being a member of the academic elite doesn’t necessarily make a good doctor, an AusDoc survey has revealed. From an experienced doctor’s perspective, high-achieving academics can face problems in practice. “Almost only the academic elite enter the system. This doesn’t necessarily make the best doctors…they are not used to failure and uncertainty and the hospital,
An expert’s roadmap to post-COVID and what it means for Pharma
COVID-19 modelling expert explains why it’s going to be trickier than many people think to vaccinate ourselves out of Delta Even as vaccination rates rise across Australia, it is unlikely that risk-averse medical practices will be allowing pharmaceutical reps to engage in face-to-face visits any time soon. So how can new digital GTM channels help to close this gap? The only certainty
5 ways Pharma can help registrars to succeed
Research study reveals GP registrars carry heavy burden of responsibility without life experience to rely on, and tools pharma can use to help GP registrars are under such stress that they are seeking out peers and crowd support to help them feel more confident in their jobs, an AusDoc survey has revealed. The Project Pathway
6 key messages you should prioritise when talking to GPs about your product
Research study shows how to better support and educate this crucial market GPs are expected to stay up-to-date with the constant changes in medicine yet, with the myriad information available, they must still navigate and interrogate multiple sources to find what they need. This information overload takes time away from the main source of GPs’ job
5 key insights to better understand and engage with medical students
Survey uncovers what medical students need and how best to connect with them Helping medical students to succeed in their studies is a key factor in getting their attention, a recent ADG survey* has found. The survey, conducted in February 2021, asked students in their final two years of study about the tensions they face and what they need
How has COVID-19 changed GP and pharmaceutical field staff engagement?
With the sudden and dramatic impact of COVID-19, a survey of GPs and their contact with pharmaceutical field staff during the pandemic reveals a massive drop in face-to-face engagement. The joint Australian Doctor Group and Medicines Australia poll was sent out in mid-May and attracted almost 400 responders. It shows prior to the pandemic half
COVID-19: Is it time for governments to start a conversation with GPs?
As Australia enters a new phase of its COVID-19 journey, governments have an increasing opportunity to engage in a two-way conversation with GPs; not only about the virus itself but also about ensuring their patients don’t ignore their general health during the pandemic. GPs are generally satisfied with the COVID-19 information they have received up to now, according to a survey of AusDoc.PLUS readers1. But a big gripe is that different information sources
How has COVID-19 changed GP digital engagement?
To download a PDF version of this infographic, please click here.
Pharma’s role in the COVID-19 crisis goes beyond new tests and treatments
Two weeks ago, on 17 March, as governments around the world began closing borders, a flight arrived at Sydney airport from the US. On board was the first consignment of thousands of new COVID-19 diagnostic testing kits that had been developed by Roche Diagnostics within weeks of the outbreak in Wuhan, China. Their arrival was
Telehealth and quality care: How COVID-19 is rapidly changing the GP landscape
GP practices across Australia are rising to the challenge of COVID-19. By far, the most widely read Australian Doctor article this week is a Quick Guide to Medicare funding for telehealth consultations. A close second is a recent article that that discusses the impact of the pandemic on day-to-day practice. Other articles and reader comments
10 reasons your content marketing needs a journalist
As the lines between journalism and marketing continue to blur, it would be rare these days to find a content marketing agency without at least one journalist on the team. Journalists bring an editorial approach to building a brand. Here’s why that’s important:
Is cancer the future of pharma?
A healthy pipeline feeds a changing treatment landscape A record number of oncology drugs was launched in 2018 with a global report recording 15 new cancer drugs for 17 indications last year. In fact, over the past five years oncology treatments appear to have taken centre stage for the pharmaceutical industry. Some 57 oncology therapies for 89